Bone metastases radiopharmaceuticals: an overview.
Vincenzo Cuccurullo1, Giuseppe Lucio Cascini, Oscar Tamburrini
1Department of Radiological Sciences - Second University of Naples, Naples, Italy.
Current Radiopharmaceuticals
|March 9, 2013
Summary
This review covers key radiocompounds for detecting bone metastases using scintigraphy and positron emission tomography (PET) imaging. These methods are crucial for diagnosing and evaluating metastatic disease in the skeleton.
Area of Science:
- Nuclear medicine
- Oncology
- Radiochemistry
Background:
- The skeleton is a common site for solid tumor metastases.
- Metastatic bone disease is the most frequent bone malignancy.
- Accurate diagnosis necessitates a multimodal approach.
Purpose of the Study:
- To review essential radiocompounds for bone metastasis detection.
- To highlight radiopharmaceuticals used in scintigraphy and PET imaging.
- To discuss the characterization of skeletal metastases.
Main Methods:
- Review of scientific literature on radiopharmaceuticals for bone imaging.
- Focus on radionuclide functional techniques: scintigraphy and PET.
- Analysis of radiocompounds for detecting and characterizing bone metastases.
Main Results:
- Scintigraphy and PET imaging are vital radionuclide techniques.
- Various radiopharmaceuticals are available for skeletal imaging.
- These methods aid in diagnosing and evaluating bone metastases.
Conclusions:
- Radiocompounds play a critical role in diagnosing bone metastases.
- Scintigraphy and PET imaging are indispensable tools.
- Effective radiopharmaceutical selection enhances metastatic disease evaluation.
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...


